Cysteine hydrochloride ( DrugBank: Cysteine )

1 disease

ID	Disease name (Link within this page)	Number of trials
254	Porphyria	2

254. Porphyria

Clinical trials : 72 / Drugs : 53 - (DrugBank : 16) / Drug target genes : 19 - Drug target pathways : 35

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004831 (ClinicalTrials.gov)	October 1996	24/2/2000	Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria		Erythropoietic Protoporphyria	Drug: cysteine hydrochloride	FDA Office of Orphan Products Development	St. Luke's-Roosevelt Hospital Center	Completed	18 Years	65 Years	Both	20	N/A	NULL
2	NCT00004940 (ClinicalTrials.gov)	May 1996	24/2/2000	Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria		Erythropoietic Protoporphyria	Drug: cysteine hydrochloride	Brigham and Women's Hospital	NULL	Completed	18 Years	65 Years	Both	50	Phase 3	NULL

First Previous1Next Last